| Literature DB >> 3301770 |
J E Baldwin, S J Killin, A J Pratt, J D Sutherland, N J Turner, M J Crabbe, E P Abraham, A C Willis.
Abstract
Isopenicillin N synthetase (IPS) cloned from Cephalosporium acremonium has been isolated from transformed Escherichia coli and purified to homogeneity. The resulting, abundant, recombinant protein, whilst undergoing slightly different N-terminal processing to that observed for the fungally-derived protein, has identical kinetics for the conversion of LLD-aminoadipoyl-cysteinyl-valine to isopenicillin N. Recombinant IPS converts analogue substrates into unusual beta-lactam antibiotics in exactly the same way as the fungal protein.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3301770 DOI: 10.7164/antibiotics.40.652
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649